Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Convergent Ventures is an early-stage venture capital firm that invests in "deep tech" companies at the intersection of biology, chemistry, physics, and data science. The firm focuses on two primary pillars: human health and planetary sustainability, backing scientific founders who are developing transformative technologies. Its portfolio includes companies specializing in areas such as genetic medicine delivery, AI-driven diagnostics, and novel materials. Convergent Ventures actively scouts and nurtures startups, providing both capital and strategic expertise to help scale science-driven innovations. The firm was formerly known as Phoenix Venture Partners and rebranded to reflect its focus on the convergence of diverse scientific fields. By bridging the gap between scientific discovery and commercial application, Convergent Ventures aims to drive significant financial returns and societal impact.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Convergent Ventures.